What if your gut could hold the key to curing chronic disease? India’s premier science body, the Council of Scientific and ...

IBD's list of the 50 Most Sustainable Companies for 2025 combines high sustainability scores and superior stock ratings. Would these be a good fit for your portfolio?

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

US clinical-stage biotech Spyre Therapeutics on Wednesday announced the closing of its previously announced underwritten public offering of 17,094,594 shares of its common stock, including the full ...

Hims stock surged Wednesday, topping a buy point, after the telehealth behemoth announced a menopause care program.

The FDA has approved an updated indication for upadacitinib (Rinvoq; AbbVie) in inflammatory bowel disease (IBD), allowing its use in adults with moderately to severely active ulcerative colitis or ...

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, ...

Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...

Depression may raise the risk for inflammatory conditions; the risk for Parkinson's disease persists after adjusting for ...

Once-daily oral obefazimod met the primary endpoint of clinical remission at 8 weeks in a highly refractory population of ...

Innovator IBD 50 ETF (FFTY) is outperforming major indexes in 2024. See here for an analysis of its risks, and whether this ...